Skip to main content
Scott Tykodi, MD, Oncology, Seattle, WA, Fred Hutchinson Cancer Center

ScottSimonTykodiMDPhD

Oncology Seattle, WA

Associate Professor, Division of Medical Oncology, University of Washington Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Dr. Tykodi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tykodi's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2000 - 2003
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1997 - 2000
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1997

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2000 - 2023
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated results for KEYNOTE-427 cohort A. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Coordinating Care for Patients with Kidney Cancer
    Coordinating Care for Patients with Kidney CancerAugust 31st, 2017
  • SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual Meeting
    SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 31st, 2018
  • ASCO Annual Meeting to Highlight Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA)
    ASCO Annual Meeting to Highlight Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA)May 21st, 2020
  • Join now to see all

Grant Support

  • Targeting Novel T Cell Antigens On Renal Cell CarcinomaNational Cancer Institute2006–2010

Professional Memberships

Hospital Affiliations